Works matching AU Tabayashi, Takayuki


Results: 27
    1
    2
    3
    4

    HLA‐matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML.

    Published in:
    EJHaem, 2025, v. 6, n. 1, p. 1, doi. 10.1002/jha2.1088
    By:
    • Mitsuyoshi, Takaya;
    • Arai, Yasuyuki;
    • Kondo, Tadakazu;
    • Kawata, Takahito;
    • Hirabayashi, Shigeki;
    • Tanaka, Masatsugu;
    • Mori, Yasuo;
    • Doki, Noriko;
    • Nishida, Tetsuya;
    • Kotani, Takeharu;
    • Ogata, Masao;
    • Tabayashi, Takayuki;
    • Eto, Tetsuya;
    • Sawa, Masashi;
    • Imada, Kazunori;
    • Kanda, Junya;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko;
    • Yanada, Masamitsu
    Publication type:
    Article
    5
    6
    7

    The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.

    Published in:
    Journal of Clinical & Experimental Hematopathology, 2020, v. 60, n. 2, p. 41, doi. 10.3960/jslrt.19039
    By:
    • Michihide Tokuhira;
    • Yuka Tanaka;
    • Yasuyuki Takahashi;
    • Yuta Kimura;
    • Tatsuki Tomikawa;
    • Tomoe Anan;
    • Junichi Watanabe;
    • Morihiko Sagawa;
    • Morihiro Higashi;
    • Shuju Momose;
    • Koichi Amano;
    • Takayuki Tabayashi;
    • Reiko Nakaseko;
    • Jun-ichi Tamaru;
    • Masahiro Kizaki
    Publication type:
    Article
    8

    The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.

    Published in:
    Journal of Clinical & Experimental Hematopathology, 2017, v. 56, n. 3, p. 165, doi. 10.3960/jslrt.56.165
    By:
    • Michihide Tokuhira;
    • Takayuki Tabayashi;
    • Yuka Tanaka;
    • Yasuyuki Takahashi;
    • Yuta Kimura;
    • Tatsuki Tomikawa;
    • Tomoe Anan-Nemoto;
    • Shuju Momose;
    • Morihiro Higashi;
    • Ayumi Okuyama;
    • Reiko Watanabe;
    • Koichi Amano;
    • Jun-ichi Tamaru;
    • Masahiro Kizaki
    Publication type:
    Article
    9
    10
    11

    Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1)

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04752-1
    By:
    • Ri, Masaki;
    • Iida, Shinsuke;
    • Saito, Kosuke;
    • Saito, Yoshiro;
    • Maruyama, Dai;
    • Asano, Arisa;
    • Fukuhara, Suguru;
    • Tsujimura, Hideki;
    • Miyazaki, Kana;
    • Ota, Shuichi;
    • Fukuhara, Noriko;
    • Negoro, Eiju;
    • Kuroda, Junya;
    • Yoshida, Shinichiro;
    • Ohtsuka, Eiichi;
    • Norifumi, Tsukamoto;
    • Tabayashi, Takayuki;
    • Takayama, Nobuyuki;
    • Saito, Toko;
    • Suzuki, Yasuhiro
    Publication type:
    Article
    12

    Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.

    Published in:
    International Journal of Hematology, 2024, v. 120, n. 1, p. 60, doi. 10.1007/s12185-024-03758-4
    By:
    • Iriyama, Noriyoshi;
    • Iwanaga, Eisaku;
    • Kimura, Yuta;
    • Watanabe, Naoki;
    • Ishikawa, Maho;
    • Nakayama, Hitomi;
    • Sato, Eriko;
    • Tabayashi, Takayuki;
    • Mitsumori, Toru;
    • Takaku, Tomoiku;
    • Nakazato, Tomonori;
    • Tokuhira, Michihide;
    • Fujita, Hiroyuki;
    • Ando, Miki;
    • Hatta, Yoshihiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    13

    Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.

    Published in:
    International Journal of Hematology, 2023, v. 118, n. 2, p. 210, doi. 10.1007/s12185-023-03606-x
    By:
    • Tokuhira, Michihide;
    • Kimura, Yuta;
    • Tabayashi, Takayuki;
    • Watanabe, Naoki;
    • Tsuchiya, Shun;
    • Takaku, Tomoiku;
    • Iriyama, Noriyoshi;
    • Sato, Eriko;
    • Nakazato, Tomonori;
    • Mitsumori, Toru;
    • Ishikawa, Maho;
    • Fujita, Hiroyuki;
    • Kizaki, Masahiro;
    • Ando, Miki;
    • Hatta, Yoshihiro;
    • Iwanaga, Eisaku;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    14
    15

    The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

    Published in:
    2009
    By:
    • Nishimori, Hisakazu;
    • Matsuo, Keitaro;
    • Maeda, Yoshinobu;
    • Nawa, Yuichiro;
    • Sunami, Kazutaka;
    • Togitani, Kazuto;
    • Takimoto, Hidetaka;
    • Hiramatsu, Yasushi;
    • Kiguchi, Toru;
    • Yano, Tomofumi;
    • Yamane, Hiromichi;
    • Tabayashi, Takayuki;
    • Takeuchi, Makoto;
    • Makita, Masanori;
    • Sezaki, Nobuo;
    • Yamasuji, Yoshiko;
    • Sugiyama, Haruko;
    • Tabuchi, Takahiro;
    • Kataoka, Itaru;
    • Fujii, Nobuharu
    Publication type:
    journal article
    16

    Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.

    Published in:
    2008
    By:
    • Hiramatsu, Yasushi;
    • Maeda, Yoshinobu;
    • Fujii, Nobuharu;
    • Saito, Takashi;
    • Nawa, Yuichiro;
    • Hara, Masamichi;
    • Yano, Tomofumi;
    • Asakura, Shoji;
    • Sunami, Kazutaka;
    • Tabayashi, Takayuki;
    • Miyata, Akira;
    • Matsuoka, Ken-ichi;
    • Shinagawa, Katsuji;
    • Ikeda, Kazuma;
    • Matsuo, Keitaro;
    • Tanimoto, Mitsune;
    • West-Japan Hematology and Oncology Group;
    • West-Japan Hematology and Oncology Group (West-JHOG)
    Publication type:
    journal article
    17
    18

    The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00366-x
    By:
    • Watanabe, Naoki;
    • Takaku, Tomoiku;
    • Iriyama, Noriyoshi;
    • Iwanaga, Eisaku;
    • Kimura, Yuta;
    • Ishikawa, Maho;
    • Nakayama, Hitomi;
    • Sato, Eriko;
    • Tabayashi, Takayuki;
    • Mitsumori, Toru;
    • Nakazato, Tomonori;
    • Tokuhira, Michihide;
    • Fujita, Hiroyuki;
    • Ando, Miki;
    • Miura, Katsuhiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 3, p. 1801, doi. 10.1007/s00277-025-06297-y
    By:
    • Katagiri, Seiichiro;
    • Akahane, Daigo;
    • Takeyama, Kunihiko;
    • Sato, Norihide;
    • Takayama, Nobuyuki;
    • Ando, Jun;
    • Nitta, Hideaki;
    • Noguchi, Masaaki;
    • Naganuma, Ken;
    • Momose, Shuji;
    • Tabayashi, Takayuki;
    • Kizaki, Masahiro;
    • Kawada, Hiroshi;
    • Kikuti, Yara Yukie;
    • Carreras, Joaquim;
    • Nakamura, Naoya;
    • Gotoh, Akihiko
    Publication type:
    Article
    27

    Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 6, p. 2021, doi. 10.1007/s00277-024-05620-3
    By:
    • Shimada, Kazuyuki;
    • Ohmachi, Ken;
    • Machida, Ryunosuke;
    • Ota, Shuichi;
    • Itamura, Hidekazu;
    • Tsujimura, Hideki;
    • Takayama, Nobuyuki;
    • Shimada, Takaki;
    • Kurosawa, Mitsutoshi;
    • Tabayashi, Takayuki;
    • Shimoyama, Tatsu;
    • Ohshima, Koichi;
    • Miyazaki, Kana;
    • Maruyama, Dai;
    • Kinoshita, Tomohiro;
    • Ando, Kiyoshi;
    • Hotta, Tomomitsu;
    • Tsukasaki, Kunihiro;
    • Nagai, Hirokazu
    Publication type:
    Article